Table S1. List of 100 Anti-Inflammatory and Anticancerous Alkaloids

Total Page:16

File Type:pdf, Size:1020Kb

Table S1. List of 100 Anti-Inflammatory and Anticancerous Alkaloids Table S1. List of 100 anti-inflammatory and anticancerous alkaloids. S. S. S. Name Name Name No. No. No. 1 Abiraterone 35 Deoxynojirimycin 69 Papaverine 2 Anagyrine 36 Dicentrine 70 Piperine 3 Anonaine 37 Diospyrin 71 Plumbagin 4 Antofine 38 Echitamine 72 Pramanicin 5 Apomorrphine 39 Eleutherin 73 Protopine 6 Arecoline 40 Ellipticine 74 Rocaglamide 7 Aristolactam 41 Emarginatine-B 75 Sanguinarine 8 Armepavine 42 Emarginatine-F 76 Saprosmine 9 Berbamine 43 Emetine 77 Shikonin 10 Berberine 44 Emodin 78 Sinomenine 11 Betanin 45 Evodiamine 79 Solamargine 12 Boldine 46 Fagaronine 80 Solanine 13 Brucine 47 Fangchinoline 81 Solasodine 14 Butein 48 Glaucine 82 Sophoridine-N-oxide 15 Caffeine 49 Harmaline 83 Streptolydigin 16 Camptothecin 50 Harmalol 84 Swainsonine 17 Canthin-6-one 51 Harmine 85 Tenuazonic-acid 18 Capsaicin 52 Homoharringtonine 86 Tetrandrine 19 Castanospermine 53 Isodiospyrin 87 Thaliandine 20 Cepharanthine 54 Lavendustin 88 Theanine 21 Chaconine 55 Liriodenine 89 Theophylline 22 Chelerythrine 56 Lobeline 90 Thiocolcichine 23 Cinchonine 57 Lunacridine 91 Tomatidine 24 Cinnamaldehyde 58 Lycorine 92 Tomatine 25 Colchicine 59 Mahanine 93 Trigonelline 26 Columbamine 60 Matrine 94 Tylocrebrine 27 Coptisine 61 Methoxycamptothecin 95 Tylophorine 28 Cordycepin 62 Murrayafoline-A 96 Vinblastine 29 Corydine 63 Neferine 97 Vincristine 30 Crebanine 64 Nitidine 98 Vinorelbine 31 Cryptolepine 65 Noscapine 99 Vinpocetine 32 Cyclopamine 66 Olaquindox 100 Voacangine 33 Dauricine 67 Oliveroline 34 Dehydrocorydaline 68 Oxostephanine Table S2. List of 100 anti-inflammatory and anticancerous flavonoids. S. S. S. Name Name Name No. No. No. 1 4-hydroxylonchocarpin 35 Gancaonin Q 69 Peonidin 2 6-prenylapigenin 36 Genistein 70 Phenoxodiol 3 Acacetin 37 Genistin 71 Phloretin 4 Aciculatin 38 Genkwanin 72 Pomiferin 5 Agathisflavone 39 Geraldol 73 Pongavilleanine 6 Alpinumisoflavone 40 Ginkgetin 74 Procyanidin 7 Amentoflavone 41 Glabridin 75 Protocatechuic acid 8 Apigenin 42 Gossypin 76 Prunetin 9 Artelasticin 43 Helichrysetin 77 Pseudobaptigenin 10 Artobiloxanthone 44 Hispidulin 78 Puerarin 11 Baicalein 45 Isoliquiritigenin 79 Quercetagetin 12 Baicalin 46 Isoxanthohumol 80 Quercetin 13 Bavachinin 47 Kaempferol 81 Rotenolone 14 Biochanin A 48 Kurarinone 82 Rotenone 15 Butein 49 Leachianone 83 Rutin 16 Cajanol 50 Lethedocin 84 Sanggenol 17 Calopocarpin 51 Licochalcone 85 Scutellarin 18 Chrysin 52 Linarin 86 Silybin 19 Coumestrol 53 Luteolin 87 Silymarin 20 Cudraflavanone A 54 Malvidin 88 Sinensetin 21 Curcumin 55 Methyltricetin 89 Squamostatin 22 Daidzein 56 Morin 90 Tangeretin 23 Deguelin 57 Morindone 91 Taxifolin 24 Delphinidin 58 Morusin 92 Tephrosin 25 Diosmetin 59 Mucronulatol 93 Theaflavin 26 Diosmin 60 Myricetin 94 Tiliroside 27 Epicatechin 61 Naringenin 95 Tricin 28 Epigallocatechin gallate 62 Naringin 96 Velutin 29 Epipervilline 63 Narirutin 97 Viscidulin 30 Eriodictyol 64 Nobiletin 98 Wogonin 31 Erybraedin C 65 Orientin 99 Xanthohumol 32 Eupafolin 66 Orobol 100 Zapotin 33 Fisetin 67 Osajin 34 Galangin 68 Panduratin Table S3. List of 100 anti-inflammatory and anticancerous terpenoids. S. S. S. Name Name Name No. No. No. 1 Abietane 35 Dehydrocostuslactone 69 Momilactone B 2 Actein 36 Dehydroeburicoic acid 70 Nimbolide 3 Amarogentin 37 Demethylzeylasterone 71 Norcantharidin 4 Amooranin 38 d-Limonene 72 Oleanolic acid 5 Andrographolide 39 Echinocystic acid 73 Oridonin 6 Ardisiacrispin A 40 Echinoside 74 Paclitaxel 7 Artesunate 41 Elephantopin 75 Paeoniflorin 8 Asiatic acid 42 Escin 76 Parthenolide 9 Aucubin 43 Eurycomanone 77 Patchoulol 10 Auraptene 44 Excisanin A 78 Perillyl alcohol 11 Azadirachtin 45 Farnesol 79 Physalin 12 Bacoside A 46 Fomitellic acid 80 Ponicidin 13 Betulinic acid 47 Ganoderic acid 81 Pristimerin 14 Bigelovin 48 Ganoderiol F 82 Protodioscin 15 Bisabolol 49 Genipin 83 Protopanaxadiol 16 Boswellic acid 50 Geraniol 84 Saikosaponin D 17 Cadalene 51 Geranylgeraniol 85 Salvicine 18 Cafestol 52 Ginsenoside 86 Santalol 19 Cannabidiol 53 Glycyrrhetinic acid 87 Sarsasapogenin 20 Cantharidin 54 Glycyrrhizin 88 Sclareol 21 Carnosic acid 55 Gnidimacrin 89 Scopoletin 22 Carnosol 56 Gossypol 90 Steviol 23 Carvone 57 Guggulsterone 91 Tanshinone 24 Catalpol 58 Gypenoside 92 Terpinen-4-ol 25 Celastrol 59 Helenalin 93 Tetrahydrocannabinol 26 Citral 60 Ingenol 94 Thymoquinone 27 Clerocidin 61 Jacoumaric acid 95 Toosendanin 28 Clerodane 62 Kahweol 96 Triptolide 29 Corosolic acid 63 Kamebakaurin 97 Ursolic acid 30 Costunolide 64 Lucidenic acid 98 Verproside 31 Cucurbitacin B 65 Lupeol 99 Vibsanin P 32 Cucurbitacin D 66 Mansonone E 100 Xanthatin 33 Cucurbitacin I 67 Maslinic acid 34 Cynaropicrin 68 Menthol .
Recommended publications
  • Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models
    molecules Review Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010–2020): A Review Maria Elaine Araruna 1, Catarina Serafim 1, Edvaldo Alves Júnior 1, Clelia Hiruma-Lima 2, Margareth Diniz 1,3 and Leônia Batista 1,3,* 1 Postgraduate Program in Natural Products and Bioactive Synthetic, Health Sciences Center, Federal University of Paraiba, João Pessoa 58051-900, PB, Brazil; [email protected] (M.E.A.); [email protected] (C.S.); [email protected] (E.A.J.); [email protected] (M.D.) 2 Department of Structural and Functional Biology (Physiology), Institute of Biosciences, São Paulo State University, Botucatu 18618-970, SP, Brazil; [email protected] 3 Department of Pharmacy, Health Sciences Center, Federal University of Paraíba, João Pessoa 58051-900, PB, Brazil * Correspondence: [email protected]; Tel.: +55-83-32167003; Fax: +55-83-32167502 Academic Editors: Maurizio Battino, Jesus Simal-Gandara and Esra Capanoglu Received: 8 September 2020; Accepted: 28 September 2020; Published: 20 November 2020 Abstract: Inflammatory bowel diseases (IBDs) refer to a group of disorders characterized by inflammation in the mucosa of the gastrointestinal tract, which mainly comprises Crohn’s disease (CD) and ulcerative colitis (UC). IBDs are characterized by inflammation of the intestinal mucosa, are highly debilitating, and are without a definitive cure. Their pathogenesis has not yet been fully elucidated; however, it is assumed that genetic, immunological, and environmental factors are involved. People affected by IBDs have relapses, and therapeutic regimens are not always able to keep symptoms in remission over the long term. Natural products emerge as an alternative for the development of new drugs; bioactive compounds are promising in the treatment of several disorders, among them those that affect the gastrointestinal tract, due to their wide structural diversity and biological activities.
    [Show full text]
  • Phase I Pharmacokinetic Trial of Perillyl Alcohol (NSC 641066) in Patients with Refractory Solid Malignancies1
    Vol. 6, 3071–3080, August 2000 Clinical Cancer Research 3071 Phase I Pharmacokinetic Trial of Perillyl Alcohol (NSC 641066) in Patients with Refractory Solid Malignancies1 Gary R. Hudes,2 Christine E. Szarka, mononuclear cells obtained from patients treated at the Andrea Adams, Sulabha Ranganathan, highest dose level. The metabolites PA and DHPA did not ras Robert A. McCauley, Louis M. Weiner, change expression or isoprenylation of p21 in MCF-7 breast or DU145 prostate carcinoma cells at concentra- Corey J. Langer, Samuel Litwin, Gwen Yeslow, tions that exceeded those achieved in patient plasma after Theresa Halberr, Mingxin Qian, and POH treatment. We conclude that POH at 1600–2100 James M. Gallo mg/m2 p.o. three times daily is well tolerated on a 14-day Departments of Medical Oncology [G. R. H., C. E. S., S. R., R. A. M., on/14-day off dosing schedule. Inhibition of p21ras func- L. M. W., C. J. L., G. Y., T. H.], Pharmacology [A. A., M. Q., tion in humans is not likely to occur after POH adminis- J. M. G.], and Biostatistics [S. L.], Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 tration at safe doses of the present oral formulation. ABSTRACT INTRODUCTION Perillyl alcohol (POH) is a monoterpene with anti- The monoterpenes are a diverse class of isoprenoid carcinogenic and antitumor activity in murine tumor molecules derived from the anabolism of acetate by the models. Putative mechanisms of action include activation mevalonic acid branch biosynthetic pathways of plants. d- of the transforming growth factor ␤ pathway and/or in- Limonene, a major component of orange peel oil and the hibition of p21ras signaling, leading to differentiation or prototype monoterpene in carcinogenesis studies, is formed apoptosis.
    [Show full text]
  • Antioxidants and Second Messengers of Free Radicals
    antioxidants Antioxidants and Second Messengers of Free Radicals Edited by Neven Zarkovic Printed Edition of the Special Issue Published in Antioxidants www.mdpi.com/journal/antioxidants Antioxidants and Second Messengers of Free Radicals Antioxidants and Second Messengers of Free Radicals Special Issue Editor Neven Zarkovic MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editor Neven Zarkovic Rudjer Boskovic Institute Croatia Editorial Office MDPI St. Alban-Anlage 66 4052 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Antioxidants (ISSN 2076-3921) from 2018 (available at: https://www.mdpi.com/journal/ antioxidants/special issues/second messengers free radicals) For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-533-5 (Pbk) ISBN 978-3-03897-534-2 (PDF) c 2019 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND. Contents About the Special Issue Editor ...................................... vii Preface to ”Antioxidants and Second Messengers of Free Radicals” ................ ix Neven Zarkovic Antioxidants and Second Messengers of Free Radicals Reprinted from: Antioxidants 2018, 7, 158, doi:10.3390/antiox7110158 ...............
    [Show full text]
  • Antiviral Activities of Oleanolic Acid and Its Analogues
    molecules Review Antiviral Activities of Oleanolic Acid and Its Analogues Vuyolwethu Khwaza, Opeoluwa O. Oyedeji and Blessing A. Aderibigbe * Department of Chemistry, University of Fort Hare, Alice Campus, Alice 5700, Eastern Cape, South Africa; [email protected] (V.K.); [email protected] (O.O.O) * Correspondence: [email protected]; Tel.: +27-406022266; Fax: +08-67301846 Academic Editors: Patrizia Ciminiello, Alfonso Mangoni, Marialuisa Menna and Orazio Taglialatela-Scafati Received: 27 July 2018; Accepted: 5 September 2018; Published: 9 September 2018 Abstract: Viral diseases, such as human immune deficiency virus (HIV), influenza, hepatitis, and herpes, are the leading causes of human death in the world. The shortage of effective vaccines or therapeutics for the prevention and treatment of the numerous viral infections, and the great increase in the number of new drug-resistant viruses, indicate that there is a great need for the development of novel and potent antiviral drugs. Natural products are one of the most valuable sources for drug discovery. Most natural triterpenoids, such as oleanolic acid (OA), possess notable antiviral activity. Therefore, it is important to validate how plant isolates, such as OA and its analogues, can improve and produce potent drugs for the treatment of viral disease. This article reports a review of the analogues of oleanolic acid and their selected pathogenic antiviral activities, which include HIV, the influenza virus, hepatitis B and C viruses, and herpes viruses. Keywords: HIV; influenza virus; HBV/HCV; natural product; triterpenoids; medicinal plant 1. Introduction Viral diseases remain a major problem for humankind. It has been reported in some reviews that there is an increase in the number of viral diseases responsible for death and morbidity around the world [1,2].
    [Show full text]
  • Original Article Effect of GABA on Blood Pressure and Blood Dynamics of Anesthetic Rats
    Int J Clin Exp Med 2015;8(8):14296-14302 www.ijcem.com /ISSN:1940-5901/IJCEM0008622 Original Article Effect of GABA on blood pressure and blood dynamics of anesthetic rats Pengju Ma1, Ting Li2, Fanceng Ji3, Haibo Wang4, Juntao Pang4 1Department of Anesthesiogy, Anqiu People’s Hospital, Anqiu 262100, China; 2Delivery Room, People’s Hospital of Anqiu, Anqiu 262100, China; 3Department of Anesthesiogy, Weifang People’s Hospital, Weifang 261041, China; 4Department of Critical Care Medicine of Weifang People’s Hospital, Weifang 261041, China Received March 31, 2015; Accepted August 13, 2015; Epub August 15, 2015; Published August 30, 2015 Abstract: Background: This study aimed to investigate GABA effects on blood pressure and blood dynamics of an- esthetic rats by observing spontaneously hypertensive rats under both anesthesia and waking state. Materials and methods: 72 male waking Wistar-Kyokos (WKY) rats and 72 male anesthetized spontaneously hypertensive (SHR) rats were randomly divided into control group and experimental group (N = 36 each). Rats were further divided into three subgroups (N = 12 each), which received 15 μmol GABA, 35 nmol muscimol, or 4 nmol dicentrine into uni- lateral paraventricular nucleus, respectively. Rats in the control group (WKY1) and experimental group (SHR1) were compared for the GABA effect on blood pressure (MAP), heart rate (HR), and arterial baroreceptor reflex function (BRS) changes under waking state. Anesthetic WKY rats (WKY2) and spontaneously hypertensive rats (SHR2) were compared for the GABA effect on those abovementioned indexes. Abdominal aorta mean arterial pressure, heart rate, and arterial baroreceptor reflex function changes were compared in all rats. Results: MAP, HR, and BRS were slightly lower in the rats under anesthetic state than in waking state before treatment (P < 0.05); they did not show significant changes between anesthetic and waking state, however, after treatment (P > 0.05).
    [Show full text]
  • Integrated Metabolomics and Transcriptomics Study of Traditional Herb Astragalus Membranaceus Bge. Var. Mongolicus
    Wu et al. BMC Genomics 2020, 21(Suppl 10):697 https://doi.org/10.1186/s12864-020-07005-y RESEARCH Open Access Integrated metabolomics and transcriptomics study of traditional herb Astragalus membranaceus Bge. var. mongolicus (Bge.) Hsiao reveals global metabolic profile and novel phytochemical ingredients Xueting Wu1†, Xuetong Li1,2†, Wei Wang3†, Yuanhong Shan1, Cuiting Wang1, Mulan Zhu1,4, Qiong La5, Yang Zhong3,5,YeXu6*, Peng Nan3* and Xuan Li1,2* From The 18th Asia Pacific Bioinformatics Conference Seoul, Korea. 18-20 August 2020 Abstract Background: Astragalus membranaceus Bge. var. mongolicus (Bge.) Hsiao is one of the most common herbs widely used in South and East Asia, to enhance people’s health and reinforce vital energy. Despite its prevalence, however, the knowledge about phytochemical compositions and metabolite biosynthesis in Astragalus membranaceus Bge. var. mongolicus (Bge.) Hsiao is very limited. (Continued on next page) * Correspondence: [email protected]; [email protected]; [email protected] †Xueting Wu, Xuetong Li and Wei Wang contributed equally to this work. 6Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China 3Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China 1Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai 200032, China Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,980,319 B2 Park Et Al
    US00898O319B2 (12) United States Patent (10) Patent No.: US 8,980,319 B2 Park et al. (45) Date of Patent: *Mar. 17, 2015 (54) METHODS OF PRODUCING STABILIZED A613 L/445 (2006.01) SOLID DOSAGE PHARMACEUTICAL A613 L/47 (2006.01) COMPOSITIONS CONTAINING A6II 45/06 (2006.01) MORPHINANS A63/67 (2006.01) (52) U.S. Cl. (71) Applicant: Mallinckrodt LLC, Hazelwood, MO CPC ............. A6 IK3I/485 (2013.01); A61 K9/1652 (US) (2013.01); A61 K9/2031 (2013.01); A61 K 9/2081 (2013.01); A61 K9/2086 (2013.01); (72) Inventors: Jae Han Park, Olivette, MO (US); A6IK9/2095 (2013.01); A61 K9/5042 Tiffani Eisenhauer, Columbia, IL (US); (2013.01); A61 K3I/4355 (2013.01); A61 K Spainty,S.Isna Gupta, F11llsborough, 31/4375A6 (2013.01); IK3I/445 gets (2013.01); it' A6 (2013.01); IK3I/47 Stephen Overholt, Middlesex, NJ (US) (2013.01); A61K 45/06 (2013.01); A61 K 9/2013 (2013.01); A61 K9/209 (2013.01); (73) Assignee: Mallinckrodt LLC, Hazelwood, MO A6 IK3I/167 (2013.01) (US) USPC ........... 424/472: 424/465; 424/468; 424/490; c - r - 514/282; 514/289 (*) Notice: Subject to any disclaimer, the term of this (58) Field of Classification Search patent is extended or adjusted under 35 N U.S.C. 154(b)b) by 0 daysyS. Seeone application file for complete search history. This patent is Subject to a terminal dis claimer. (56) References Cited (21) Appl. No.: 14/092.375 U.S. PATENT DOCUMENTS (22) Filed: Nov. 27, 2013 2008, 0026052 A1 ck 1/2008 Schoenhard .................
    [Show full text]
  • An in Silico Study of the Ligand Binding to Human Cytochrome P450 2D6
    AN IN SILICO STUDY OF THE LIGAND BINDING TO HUMAN CYTOCHROME P450 2D6 Sui-Lin Mo (Doctor of Philosophy) Discipline of Chinese Medicine School of Health Sciences RMIT University, Victoria, Australia January 2011 i Declaration I hereby declare that this submission is my own work and to the best of my knowledge it contains no materials previously published or written by another person, or substantial proportions of material which have been accepted for the award of any other degree or diploma at RMIT university or any other educational institution, except where due acknowledgment is made in the thesis. Any contribution made to the research by others, with whom I have worked at RMIT university or elsewhere, is explicitly acknowledged in the thesis. I also declare that the intellectual content of this thesis is the product of my own work, except to the extent that assistance from others in the project‘s design and conception or in style, presentation and linguistic expression is acknowledged. PhD Candidate: Sui-Lin Mo Date: January 2011 ii Acknowledgements I would like to take this opportunity to express my gratitude to my supervisor, Professor Shu-Feng Zhou, for his excellent supervision. I thank him for his kindness, encouragement, patience, enthusiasm, ideas, and comments and for the opportunity that he has given me. I thank my co-supervisor, A/Prof. Chun-Guang Li, for his valuable support, suggestions, comments, which have contributed towards the success of this thesis. I express my great respect to Prof. Min Huang, Dean of School of Pharmaceutical Sciences at Sun Yat-sen University in P.R.China, for his valuable support.
    [Show full text]
  • Relation Structure/Activité De Tanins Bioactifs Contre Les Nématodes
    En vue de l'obtention du DOCTORAT DE L'UNIVERSITÉ DE TOULOUSE Délivré par : Institut National Polytechnique de Toulouse (INP Toulouse) Discipline ou spécialité : Pathologie, Toxicologie, Génétique et Nutrition Présentée et soutenue par : Mme JESSICA QUIJADA PINANGO le jeudi 17 décembre 2015 Titre : RELATION STRUCTURE/ACTIVITE DE TANINS BIOACTIFS CONTRE LES NEMATODES GASTROINTESTINAUX (HAEMONCHUS CONTORTUS) PARASITES DES PETITS RUMINANTS Ecole doctorale : Sciences Ecologiques, Vétérinaires, Agronomiques et Bioingénieries (SEVAB) Unité de recherche : Interactions Hôtes - Agents Pathogènes (IHAP) Directeur(s) de Thèse : M. HERVÉ HOSTE Rapporteurs : M. ADIBE LUIZ ABDALLA, UNIVERSIDAD DE SAO PAULO Mme HEIDI ENEMARK, NORWEGIAN VETERINARY INSTITUTE Membre(s) du jury : 1 M. FRANÇOIS SCHELCHER, ECOLE NATIONALE VETERINAIRE DE TOULOUSE, Président 2 M. HERVÉ HOSTE, INRA TOULOUSE, Membre 2 Mme CARINE MARIE-MAGDELAINE, INRA PETIT BOURG, Membre 2 M. SMARO SOTIRAKI, HAO-DEMETER, Membre 2 M. VINCENT NIDERKORN, INRA CLERMONT FERRAND, Membre QUIJADA J. 2015 Cette thèse est dédiée à mes parents, Teresa et Héctor, À mon mari, Rafäel, pour son soutien inconditionnel, son amour illimité, sa patience, sa loyauté, son amitié et surtout sa confidence, À ma grand-mère, Marcolina, car m'ait donné le plus grand et précieux cadeau en ma vie : ma foi en Dieu ma forteresse et mon espoir (Isaïas 41:13). À mes adorés sœurs, belle- sœurs et frère : Yurlin, Indira, Iskay, Olga, Zoraida et Jesus. Merci pour l’amour infini que m’ont toujours été donné, celui qu’a été prolongé par l'amour de mes merveilleux neveux. 1 QUIJADA J. 2015 REMERCIEMENTS Je remercie tout d’abord mon Dieu pour me donner le cadeau de la vie, et la forteresse pour vivre chaque jour.
    [Show full text]
  • Plant Secondary Metabolites .Pdf
    PLANT SECONDARY METABOLITES W W W . T R C - C A N A D A . C O M +1 (416) 665-9696 www.trc-canada.com 2 Brisbane Road, Toronto [email protected] Plant Secondary Metabolites Product CAS No CAT No Acanthopanax senticosides B 114902-16-8 Please Inquire Acetyl resveratrol 42206-94-0 R150055 Acetylshikonin 24502-78-1 Please Inquire Acronycine 7008-42-6 Please Inquire Acteoside 61276-17-3 V128000 Agrimol B 55576-66-4 Please Inquire Alisol-B-23-acetate 26575-95-1 A535970 Alisol-C-monoacetate 26575-93-9 Please Inquire Alizarin 72-48-0 A536600 Alkannin 517-88-4 Please Inquire Allantoin 97-59-6 A540500 Allantoin-13C2,15N4 1219402-51-3 A540502 Alliin 556-27-4 A543530 Aloe emodin 481-72-1 A575400 Aloe-emodin-d5 1286579-72-3 A575402 Aloenin A 38412-46-3 Please Inquire Aloin A 1415-73-2 A575415 Amentoflavone 1617-53-4 A576420 Amygdalin 29883-15-6 A576840 Andrographolide 5508-58-7 A637475 Angelicin 523-50-2 A637575 Anhydroicaritin 118525-40-9 I163700 Anisodamine 55869-99-3 Please Inquire Anthraquinone 84-65-1 A679245 Anthraquinone-D8 10439-39-1 A679247 Apigenin 520-36-5 A726500 Apigenin-d5 263711-74-6 A726502 Araloside X 344911-90-6 Please Inquire www.trc-canada.com I +1 (416) 665-9696 I [email protected] Plant Secondary Metabolites Arbutin 497-76-7 A766510 Arbutin-13C6 A766512 Arctigenin 7770-78-7 A766580 Arctiin 20362-31-6 A766575 Aristolochic acid I 313-67-7 A771300 Aristolochic acid II 475-80-9 A771305 Aristolochic acid sodium salt 10190-99-5 Please Inquire Aristololactam 13395-02-3 A771200 Artemisinin 63968-64-9 A777500 Artemisinin-d3 176652-07-6
    [Show full text]
  • Dicentrine Production from a Hairy Roots Culture of Stephania Suberosa
    Dicentrine Production from a Hairy Roots Culture of Stephania suberosa Waraporn Putalun*, Gorawit Yusakul, and Denpong Patanasethanont Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand. Fax: +66-43-2 02-3 79. E-mail: [email protected] * Author for correspondence and reprint requests Z. Naturforsch. 64 c, 692 – 696 (2009); received June 8/July 2, 2009 A hairy roots culture of Stephania suberosa was established using Agrobacterium rhizo- genes ATCC15834. The production of dicentrine was found to be (8.92 ± 0.07) mg/g dry wt on day 35 of culture. Effects of sucrose content, tyrosine, and medium strength on growth and dicentrine production of S. suberosa were investigated. 6% (w/v) sucrose was an op- timum content for the growth and dicentrine accumulation in S. suberosa hairy roots. The utilization of a precursor from tyrosine feeding enhanced the dicentrine production. The medium with 1.0 mM of tyrosine had the highest effect on dicentrine accumulation in hairy roots at day 40 of culture [(14.73 ± 0.47) mg/g dry wt]. In addition, ¼ Murashige and Skoog medium was suitable for biomass and dicentrine production in hairy roots. This culture sys- tem has a potential to produce dicentrine from hairy roots of S. suberosa. Key words: Dicentrine, Hairy Roots, Stephania suberosa Introduction achieved in S. suberosa tuberous roots (Patra et al., 1986; Sriprang et al., 2006). Therefore, hairy Stephania suberosa Forman (Menispermaceae) roots cultures of S. suberosa are necessary for the is a medicinal plant which has been used in Thai production of biological compounds. It is known traditional medicine for the treatment of hyper- that many factors could affect the secondary me- tension.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2011/0268722 A1 Siegelin Et Al
    US 20110268722A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0268722 A1 Siegelin et al. (43) Pub. Date: Nov. 3, 2011 (54) COMBINATION THERAPIES WITH Publication Classification MTOCHONORAL-TARGETED (51) Int. Cl ANT-TUMIORAGENTS A638/17 (2006.01) CI2N 5/071 (2010.01) (76) Inventors: Markus D. Siegelin, Weehawken, A6IP35/00 (2006.01) NJ (US); Dario C. Altieri, A 6LX 39/395 (2006.01) Worcester, MA (US) C07D 225/06 (2006.01) (52) U.S. Cl. ..................... 424/130.1; 514/18.9; 540/461; (21) Appl. No.: 13/092,475 435/375 (57) ABSTRACT (22) Filed: Apr. 22, 2011 Described are mitochondria-targeted anti-tumor agents, death receptor agonists, autophagy inhibitors, and NF-KB Related U.S. Application Data signaling pathway inhibitors, and methods of making and (60) Provisional application No. 61/326,872, filed on Apr. using the same for the treatment of disorders associated with 22, 2010. unwanted cell proliferation. Patent Application Publication Nov. 3, 2011 Sheet 1 of 13 US 2011/0268722 A1 120% 8: 8: 8 CE 60% : 5 P_GA s : RA 2:: : P-GA-RA : : 8 N3 FAS Figure 1A Patent Application Publication Nov. 3, 2011 Sheet 2 of 13 US 2011/0268722 A1 igure 1B ---, igure 2A Figure 2B Patent Application Publication Nov. 3, 2011 Sheet 3 of 13 US 2011/0268722 A1 8. s::::::: se: -83.383.3 ---sixxxxx:----- --~~~x-x-x-xxii. : s: 8 i88 s: sig ::::::: ...i Figure 2C Figure 2D Figure 3A Figure 3B Patent Application Publication Nov. 3, 2011 Sheet 4 of 13 US 2011/0268722 A1 ::: :*:: & : : isix; {S3.g3-8 : Exx8:8-3 : {kari 333333.
    [Show full text]